Neuro-Bio’s CEO debate at the House of Lords.

Neuro-Bio’s CEO debate at the House of Lords.

On Tuesday the 17th of May, Neuro-Bio's CEO, Baroness Susan Greenfield, had a debate at the House of Lords, in London. The principal topics for the debate will be education, welfare, health and public services, therefore Susan Greenfield will be talking about the...

read more
Georgia Price joins Neuro-Bio!

Georgia Price joins Neuro-Bio!

Neuro-bio welcomes Georgia Price as part of the team! Georgia is currently undertaking a DPhil at the University of Oxford studying neurodegenerative diseases after completing her undergraduate degree in Biomedical Science from the University of Sheffield. After...

read more
Linda Morgan joins Neuro-Bio !

Linda Morgan joins Neuro-Bio !

Neuro-Bio welcomes Linda Morgan as new Finance Manager. Linda has a wide range of experience in accountancy. After graduating from the University of Brighton with a BA (hons) degree in Accounting and Finance she went on to work for an accounting practice in Oxford...

read more
Neuro-Bio and Tino Rossi are now collaborating together.

Neuro-Bio and Tino Rossi are now collaborating together.

Neuro-Bio is now collaborating with Tino Rossi. Tino has over 40 years of experience in drug discovery and development having occupied roles of growing seniority and leadership  in Medicinal Chemistry, Chemical Development and Preclinical Drug Discovery in the...

read more
Mark I. Butler joins Neuro-Bio!

Mark I. Butler joins Neuro-Bio!

Neuro-Bio welcomes Mark I. Butler as new COO Designate. Mark holds a Ph.D. in Pharmacology from the University of Bristol, where he completed a "bench-to-bedside'' thesis focusing on the mechanisms of new antiplatelet agents. He has over ten years experience managing...

read more
ArabicChinese (Simplified)EnglishRussian